The programme has been developed by the University of Cambridge Institute of Continuing Education and Cambridge University Hospitals in partnership with Wellcome Sanger Institute, Wellcome Genome Campus Advanced Courses and Scientific Conferences, and EMBL-European Bioinformatics Institute.
This is a part-time course designed to fit with the demands of full-time employment. The course is delivered through a combination of face-to-face sessions requiring attendance in Cambridge, self-directed learning and supported through a virtual learning environment [VLE].
Aims of the programme
- To provide professionally relevant teaching and learning informed by research in an integrated clinical and research environment;
- To develop and create a cohort of doctors and other professionals allied to medicine able to pursue and develop their roles in a rapidly-changing and challenging environment of genomic medicine;
- To prepare healthcare professionals for the adoption of genomic technologies and the increasing use of genomic information as part of the diagnostic and treatment pathway;
- To develop a cohort of doctors and other professionals allied to medicine with the confidence to lead service improvement for safe and high quality patient care, and with the required knowledge, skills and capability to have a positive personal impact on the work of others;
- To develop a cohort of doctors and other professionals allied to medicine with an understanding of research methodologies and clinical opportunities relevant to genomic medicine;
- To encourage a commitment to intellectual challenge and evidence-based clinical practice informed by the latest conceptual and theoretical knowledge of genomic medicine;
- To develop students' intellectual, practical and transferable skills related to genomic medicine;
- To encourage critical thinking related to genomic medicine;
Teaching and Learning
The PG Diploma is a two year course and students must complete eight modules. There is additional between-module reflection, study and assignment work. The introductory module in October is compulsory for all students.
Students choose eight modules (four modules to be taken in year one of the course):
Please note that dates for these modules are provisional and may be changed in accordance with government/University guidelines.
* Mandatory modules for all students
•An introduction to human genetics and genomics (GM1A): 10 - 14 October 2022*
•Omics techniques and their application to genomic medicine (GM2): 31 October - 4 November 2022
•Bioinformatics, interpretation and data quality assurance in genome analysis (GM7): 5 - 9 December 2022
•Application of genomics in infectious disease (GM5): 9 - 13 January 2023
•Molecular pathology of cancer and application in cancer diagnosis, screening, and treatment (GM4): 6 - 10 February 2023
•Pharmacogenetics and stratified healthcare (GM6): 27 February - 3 March 2023
•Counselling skills for genomics (GMO2): 20 - 24 March 2023
•Advanced bioinformatics - from genomes to systems (GMO4): TBC
•Epigenetics and epigenomics (GMO5): 24 - 28 April 2023
•Genomics of common and rare inherited diseases (GM3): 15 - 19 May 2023
•Expanding the content of the MSt in genomic medicine with a workplace-based module (GMO6): May-June 2023
•Research and statistical skills in genomic medicine (GMO7) various
To meet eligibility requirements, some funding providers such as HEE may require the study of specific modules.
Further study options:
The Genomic Medicine programme, provides the following additional course and study options:
To note: all module options will not necessarily be offered in any one year.